194 related articles for article (PubMed ID: 4322937)
1. Demonstration of cell-mediated immunity to human neoplasms of various histological types.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Jan; 7(1):1-16. PubMed ID: 4322937
[No Abstract] [Full Text] [Related]
2. Cellular and humoral immunity to different types of human neoplasms.
Hellström I; Hellström KE; Pierce GE; Yang JP
Nature; 1968 Dec; 220(5174):1352-4. PubMed ID: 4302696
[No Abstract] [Full Text] [Related]
3. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
Hellström I; Sjögren HO; Warner G; Hellström KE
Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
[No Abstract] [Full Text] [Related]
4. Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs.
Khoo SK; Warner NL; Lie JT; Mackay IR
Int J Cancer; 1973 May; 11(3):681-7. PubMed ID: 4791225
[No Abstract] [Full Text] [Related]
5. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
Drewinko B; Montgomery CT; Trujillo JM
Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
[No Abstract] [Full Text] [Related]
6. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
[No Abstract] [Full Text] [Related]
7. Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.
Hellström I; Hellström KE; Warner GA
Int J Cancer; 1973 Sep; 12(2):348-53. PubMed ID: 4792348
[No Abstract] [Full Text] [Related]
8. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
9. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
[No Abstract] [Full Text] [Related]
10. Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solution.
Mavligit GM; Gutterman JU; Hersh EM
Immunol Commun; 1973; 2(5):463-72. PubMed ID: 4518928
[No Abstract] [Full Text] [Related]
11. [6 cases of second primary neoplasms].
Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
[No Abstract] [Full Text] [Related]
12. Studies on specificity of cell-mediated immunity to human tumors.
Takasugi M; Mickey MR; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
[No Abstract] [Full Text] [Related]
13. Carcinoembryonic antigen in patients with gynecologic malignancies.
DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
[TBL] [Abstract][Full Text] [Related]
14. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Bolton PM
Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
[No Abstract] [Full Text] [Related]
15. Detection of carcinoembryonic antigen in the media of cultures of carcinomatous cells of digestive-system origin.
Laing CA; Heppner GH; Kopp LE; Calabresi P
J Natl Cancer Inst; 1972 Jun; 48(6):1909-11. PubMed ID: 5066473
[No Abstract] [Full Text] [Related]
16. [Detection of a common cancer antigen in several human tumors of different location].
Rogal'skiĭ VIa
Biull Eksp Biol Med; 1967 Mar; 63(3):110-2. PubMed ID: 4988279
[No Abstract] [Full Text] [Related]
17. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
Catalona WJ; Sample WF; Chretien PB
Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045
[No Abstract] [Full Text] [Related]
18. Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.
Sjögren HO; Hellström I; Bansal SC; Warner GA; Hellström KE
Int J Cancer; 1972 Mar; 9(2):274-83. PubMed ID: 4504846
[No Abstract] [Full Text] [Related]
19. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
Rote NS; Smith WG; Johnson GH
Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
[No Abstract] [Full Text] [Related]
20. Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer.
Thornes RD
Lancet; 1974 Aug; 2(7877):382-4. PubMed ID: 4137344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
